Literature DB >> 24112971

The impact of the receptor binding profiles of the vascular endothelial growth factors on their angiogenic features.

Tiina Nieminen1, Pyry I Toivanen, Nina Rintanen, Tommi Heikura, Suvi Jauhiainen, Kari J Airenne, Kari Alitalo, Varpu Marjomäki, Seppo Ylä-Herttuala.   

Abstract

BACKGROUND: Vascular endothelial growth factors (VEGFs) are potential therapeutic agents for treatment of ischemic diseases. Their angiogenic effects are mainly mediated through VEGF receptor 2 (VEGFR2).
METHODS: Receptor binding, signaling, and biological efficacy of several VEGFR2 ligands were compared to determine their characteristics regarding angiogenic activity and vascular permeability.
RESULTS: Tested VEGFR2 ligands induced receptor tyrosine phosphorylation with different efficacy depending on their binding affinities. However, the tyrosine phosphorylation pattern and the activation of the major downstream signaling pathways were comparable. The maximal angiogenic effect stimulated by different VEGFR2 ligands was dependent on their ability to bind to co-receptor Neuropilin (Nrp), which was shown to form complexes with VEGFR2. The ability of these VEGFR2 ligands to induce vascular permeability was dependent on their concentration and VEGFR2 affinity, but not on Nrp binding.
CONCLUSIONS: VEGFR2 activation alone is sufficient for inducing endothelial cell proliferation, formation of tube-like structures and vascular permeability. The level of VEGFR2 activation is dependent on the binding properties of the ligand used. However, closely similar activation pattern of the receptor kinase domain is seen with all VEGFR2 ligands. Nrp binding strengthens the angiogenic potency without increasing vascular permeability. GENERAL SIGNIFICANCE: This study sheds light on how different structurally closely related VEGFR2 ligands bind to and signal via VEGFR2/Nrp complex to induce angiogenesis and vascular permeability. The knowledge of this study could be used for designing VEGFR2/Nrp ligands with improved therapeutic properties.
© 2013.

Entities:  

Keywords:  Angiogenesis; HEK293T cells; HSPGs; HUVECs; Heat shock protein 27; His-tag; Hsp27; Neuropilin; Nrp; PAE cells; PLCγ; PlGF; Receptor activation; T-cell-specific adapter; TSAd; VE-cadherin; VEGF; VEGF receptor 2; VEGFR2; Vascular endothelial growth factor; heparan sulfate proteoglycans; hexahistidine tag; human embryonic kidney 293T cells; human umbilical vein endothelial cells; phospholipase Cγ; placenta growth factor; porcine aortic endothelial cells; sNrp1-Fc; soluble Nrp1 IgG Fc fragment fusion protein; vascular endothelial cadherin; vascular endothelial growth factor

Mesh:

Substances:

Year:  2013        PMID: 24112971     DOI: 10.1016/j.bbagen.2013.10.005

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Mannan-modified adenovirus encoding VEGFR-2 as a vaccine to induce anti-tumor immunity.

Authors:  Jie Zhang; Ying Wang; Yang Wu; Zhen-Yu Ding; Xin-Mei Luo; Wu-Ning Zhong; Jie Liu; Xiang-Yu Xia; Guo-Hua Deng; Yao-Tiao Deng; Yu-Quan Wei; Yu Jiang
Journal:  J Cancer Res Clin Oncol       Date:  2014-02-14       Impact factor: 4.553

2.  Prostaglandin E2 and vascular endothelial growth factor A mediate angiogenesis of human ovarian follicular endothelial cells.

Authors:  Heidi A Trau; Mats Brännström; Thomas E Curry; Diane M Duffy
Journal:  Hum Reprod       Date:  2016-01-05       Impact factor: 6.918

3.  Snake venom VEGF Vammin induces a highly efficient angiogenic response in skeletal muscle via VEGFR-2/NRP specific signaling.

Authors:  Pyry I Toivanen; Tiina Nieminen; Johanna P Laakkonen; Tommi Heikura; Minna U Kaikkonen; Seppo Ylä-Herttuala
Journal:  Sci Rep       Date:  2017-07-17       Impact factor: 4.379

4.  Alternative mRNA Splicing in Three Venom Families Underlying a Possible Production of Divergent Venom Proteins of the Habu Snake, Protobothrops flavoviridis.

Authors:  Tomohisa Ogawa; Naoko Oda-Ueda; Kanako Hisata; Hitomi Nakamura; Takahito Chijiwa; Shousaku Hattori; Akiko Isomoto; Haruki Yugeta; Shinichi Yamasaki; Yasuyuki Fukumaki; Motonori Ohno; Noriyuki Satoh; Hiroki Shibata
Journal:  Toxins (Basel)       Date:  2019-10-09       Impact factor: 4.546

5.  Adenoviral VEGF-B186R127S gene transfer induces angiogenesis and improves perfusion in ischemic heart.

Authors:  Henna Korpela; Olli-Pekka Hätinen; Tiina Nieminen; Rahul Mallick; Pyry Toivanen; Jonna Airaksinen; Kaisa Valli; Mikko Hakulinen; Pekka Poutiainen; Jussi Nurro; Seppo Ylä-Herttuala
Journal:  iScience       Date:  2021-11-27

6.  Peroxisome proliferator‑activated receptor γ mediates porcine placental angiogenesis through hypoxia inducible factor‑, vascular endothelial growth factor‑ and angiopoietin‑mediated signaling.

Authors:  Juzuo Zhang; Xuan Peng; Anwen Yuan; Yang Xie; Qing Yang; Liqun Xue
Journal:  Mol Med Rep       Date:  2017-06-30       Impact factor: 2.952

Review 7.  Molecular Pharmacology of VEGF-A Isoforms: Binding and Signalling at VEGFR2.

Authors:  Chloe J Peach; Viviane W Mignone; Maria Augusta Arruda; Diana C Alcobia; Stephen J Hill; Laura E Kilpatrick; Jeanette Woolard
Journal:  Int J Mol Sci       Date:  2018-04-23       Impact factor: 5.923

8.  Adenoviral intramyocardial VEGF-DΔNΔC gene transfer increases myocardial perfusion reserve in refractory angina patients: a phase I/IIa study with 1-year follow-up.

Authors:  Juha Hartikainen; Iiro Hassinen; Antti Hedman; Antti Kivelä; Antti Saraste; Juhani Knuuti; Minna Husso; Hanna Mussalo; Marja Hedman; Tuomas T Rissanen; Pyry Toivanen; Tommi Heikura; Joseph L Witztum; Sotirios Tsimikas; Seppo Ylä-Herttuala
Journal:  Eur Heart J       Date:  2017-09-01       Impact factor: 29.983

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.